Go Pro

MarketBeat Instant News Alerts

ANI Pharmaceuticals logo with Healthcare background

Canaccord Genuity Group Cuts ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $90.00

Canaccord Genuity Group cut their price target on ANI Pharmaceuticals from $91.00 to $90.00 and set a "hold" rating for the company in a research note on Monday.

NASDAQ:ANIP
Read Canaccord Genuity Group Cuts ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $90.00
Bridger Aerospace Group logo with Industrials background

Bridger Aerospace Group (NASDAQ:BAER) Given New $4.00 Price Target at Canaccord Genuity Group

Canaccord Genuity Group reduced their target price on Bridger Aerospace Group from $4.50 to $4.00 and set a "buy" rating on the stock in a research note on Monday.

NASDAQ:BAER
Read Bridger Aerospace Group (NASDAQ:BAER) Given New $4.00 Price Target at Canaccord Genuity Group
Biodesix logo with Healthcare background

Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price

Canaccord Genuity Group lifted their target price on Biodesix from $27.00 to $35.00 and gave the stock a "buy" rating in a report on Monday.

NASDAQ:BDSX
Read Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price
BioMarin Pharmaceutical logo with Healthcare background

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $114.00 at Canaccord Genuity Group

Canaccord Genuity Group upped their target price on shares of BioMarin Pharmaceutical from $111.00 to $114.00 and gave the company a "buy" rating in a research note on Monday.

NASDAQ:BMRN
Read BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $114.00 at Canaccord Genuity Group
Interface logo with Industrials background

Barrington Research Forecasts Strong Price Appreciation for Interface (NASDAQ:TILE) Stock

Barrington Research lifted their price objective on shares of Interface from $36.00 to $45.00 and gave the company an "outperform" rating in a report on Monday.

NASDAQ:TILE
Read Barrington Research Forecasts Strong Price Appreciation for Interface (NASDAQ:TILE) Stock
Claritev logo with Healthcare background

Claritev (NYSE:CTEV) Price Target Raised to $43.00

Canaccord Genuity Group boosted their price objective on Claritev from $37.00 to $43.00 and gave the stock a "buy" rating in a research note on Monday.

NYSE:CTEV
Read Claritev (NYSE:CTEV) Price Target Raised to $43.00

Trending News

All MarketBeat Instant News Alerts

California Resources logo with Energy background

California Resources (NYSE:CRC) Announces Quarterly Earnings Results, Misses Expectations By $0.37 EPS

NYSE:CRC
Read California Resources (NYSE:CRC) Announces Quarterly Earnings Results, Misses Expectations By $0.37 EPS
Cogent Biosciences logo with Healthcare background

Cogent Biosciences (NASDAQ:COGT) Announces Earnings Results

NASDAQ:COGT
Read Cogent Biosciences (NASDAQ:COGT) Announces Earnings Results
Conduent logo with Industrials background

Conduent (NASDAQ:CNDT) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

NASDAQ:CNDT
Read Conduent (NASDAQ:CNDT) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS
Quanterix logo with Healthcare background

Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results

NASDAQ:QTRX
Read Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results
PowerFleet logo with Technology background

PowerFleet (NASDAQ:AIOT) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

NASDAQ:AIOT
Read PowerFleet (NASDAQ:AIOT) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Tonix Pharmaceuticals logo with Healthcare background

Tonix Pharmaceuticals (NASDAQ:TNXP) Announces Earnings Results

NASDAQ:TNXP
Read Tonix Pharmaceuticals (NASDAQ:TNXP) Announces Earnings Results
Jerash Holdings (US) logo with Consumer Discretionary background

Jerash Holdings (US) (NASDAQ:JRSH) Issues Quarterly Earnings Results

NASDAQ:JRSH
Read Jerash Holdings (US) (NASDAQ:JRSH) Issues Quarterly Earnings Results
Heron Therapeutics logo with Healthcare background

Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results

NASDAQ:HRTX
Read Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results
Lincoln Educational Services logo with Consumer Discretionary background

Lincoln Educational Services (NASDAQ:LINC) Releases FY 2026 Earnings Guidance

NASDAQ:LINC
Read Lincoln Educational Services (NASDAQ:LINC) Releases FY 2026 Earnings Guidance
Guidewire Software logo with Technology background

Piper Sandler Begins Coverage on Guidewire Software (NYSE:GWRE)

NYSE:GWRE
Read Piper Sandler Begins Coverage on Guidewire Software (NYSE:GWRE)
Agilysys logo with Technology background

Needham & Company LLC Issues Positive Forecast for Agilysys (NASDAQ:AGYS) Stock Price

NASDAQ:AGYS
Read Needham & Company LLC Issues Positive Forecast for Agilysys (NASDAQ:AGYS) Stock Price
Consensus Cloud Solutions logo with Technology background

BTIG Research Forecasts Strong Price Appreciation for Consensus Cloud Solutions (NASDAQ:CCSI) Stock

NASDAQ:CCSI
Read BTIG Research Forecasts Strong Price Appreciation for Consensus Cloud Solutions (NASDAQ:CCSI) Stock
Compass Minerals International logo with Materials background

JPMorgan Chase & Co. Reaffirms "Underweight" Rating for Compass Minerals International (NYSE:CMP)

NYSE:CMP
Read JPMorgan Chase & Co. Reaffirms "Underweight" Rating for Compass Minerals International (NYSE:CMP)
Knife River logo with Materials background

Knife River (NYSE:KNF) Given New $80.00 Price Target at JPMorgan Chase & Co.

NYSE:KNF
Read Knife River (NYSE:KNF) Given New $80.00 Price Target at JPMorgan Chase & Co.
Kestra Medical Technologies logo with Healthcare background

Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by JPMorgan Chase & Co.

NASDAQ:KMTS
Read Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by JPMorgan Chase & Co.
Ultragenyx Pharmaceutical logo with Healthcare background

Ultragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright

NASDAQ:RARE
Read Ultragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright
Emergent Biosolutions logo with Healthcare background

Emergent Biosolutions (NYSE:EBS) Given New $10.00 Price Target at HC Wainwright

NYSE:EBS
Read Emergent Biosolutions (NYSE:EBS) Given New $10.00 Price Target at HC Wainwright
Adient logo with Consumer Discretionary background

Barclays Lowers Adient (NYSE:ADNT) Price Target to $25.00

NYSE:ADNT
Read Barclays Lowers Adient (NYSE:ADNT) Price Target to $25.00
Prime Medicine logo with Healthcare background

Prime Medicine's (PRME) "Buy" Rating Reaffirmed at HC Wainwright

NASDAQ:PRME
Read Prime Medicine's (PRME) "Buy" Rating Reaffirmed at HC Wainwright
Surrozen logo with Healthcare background

HC Wainwright Reiterates "Buy" Rating for Surrozen (NASDAQ:SRZN)

NASDAQ:SRZN
Read HC Wainwright Reiterates "Buy" Rating for Surrozen (NASDAQ:SRZN)
Howmet Aerospace logo with Industrials background

Howmet Aerospace (NYSE:HWM) Price Target Raised to $340.00

NYSE:HWM
Read Howmet Aerospace (NYSE:HWM) Price Target Raised to $340.00
Essent Group logo with Finance background

Barclays Raises Essent Group (NYSE:ESNT) Price Target to $65.00

NYSE:ESNT
Read Barclays Raises Essent Group (NYSE:ESNT) Price Target to $65.00
Better Home & Finance logo with Finance background

BTIG Research Lowers Better Home & Finance (NASDAQ:BETR) Price Target to $23.00

NASDAQ:BETR
Read BTIG Research Lowers Better Home & Finance (NASDAQ:BETR) Price Target to $23.00
Hillman Solutions logo with Industrials background

Hillman Solutions (NASDAQ:HLMN) Price Target Raised to $11.00

NASDAQ:HLMN
Read Hillman Solutions (NASDAQ:HLMN) Price Target Raised to $11.00

Featured Articles and Offers

Alert Categories

All Alerts